Abstract
This case report describes a patient who underwent implantation of a bare-metal stent (BMS) for the treatment of everolimus-eluting stent (EES) restenosis caused by chronic stent recoil, and the BMS successfully escaped from duplicate restenosis and target lesion revascularization (TLR).
This is a preview of subscription content, log in via an institution to check access.
References
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group (2002) Randomized study with the Sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780
Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T (2014) Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound. Heart Vessels. doi:10.1007/s00380-014-0545-0
Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Otto-Terlouw PC (2005) A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention 1:58–65
Applegate RJ, Yaqub M, Hermiller JB, Sood P, Yu S, Doostzadeh J, Williams JE, Farhat N, Caputo R, Lansky AJ, Cutlip DE, Sudhir K, Stone GW (2011) Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). Am J Cardiol 107:833–840
Dörr O, Liebetrau C, Wiebe J, Hecker F, Rixe J, Möllmann H, Hamm C, Nef H (2014) Bioresorbable scaffolds for the treatment of in-stent restenosis. Heart Vessels. doi:10.1007/s00380-013-0464-5
Lemos PA, van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW (2004) Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 109:2500–2502
Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123:2954–2963
van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, de Feijter PJ, Serruys PW, van der Giessen WJ (2007) Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 28:974–979
Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA (2007) Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 70:515–523
Haude M, Erbel R, Issa H, Meyer J (1993) Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol 21:26–34
Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama T, Nakatani D, Otake H, Yamasaki M, Sakurai R, Tsujino I, Honda Y, Fitzgerald PJ (2010) Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents. Int J Cardiol 144:132–134
Ratib K, Doshi SN, Townend JN (2005) Double-stenting of an ostial left main-stem lesion for elastic recoil. Int J Cardiol 102:357–358
Tsunoda T, Nakamura M, Wada M, Ito N, Kitagawa Y, Shiba M, Yajima S, Iijima R, Nakajima R, Yamamoto M, Takagi T, Yoshitama T, Anzai H, Nishida T, Yamaguchi T (2004) Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 15:39–44
Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C (2008) Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease. Cardiology 111:270–276
He Y, Maehara A, Mintz GS, Bharaj H, Castellanos C, Kesanakurthy S, Wu X, Guo N, Choi SY, Leon MB, Stone GW, Mehran R, Rabbani LE, Moses JW (2010) Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. Am J Cardiol 105:1272–1275
Ako J, Bonneau HN, Honda Y, Fitzgerald PJ (2007) Design criteria for the ideal drug-eluting stent. Am J Cardiol 100:3M–9M
Williams PD, Appleby CE, Chowdhary S, Fraser DG (2011) Double stenting: a method for treating acute stent recoil and luminal filling defects. EuroIntervention 6:846–853
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4:149–154
Acknowledgments
We are grateful to the staff of the ICU and cardiovascular center at Chiba Hokusoh Hospital, Nippon Medical School.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shirakabe, A., Takano, M., Yamamoto, M. et al. Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment. Heart Vessels 31, 434–437 (2016). https://doi.org/10.1007/s00380-014-0588-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-014-0588-2